A New Class of Anti-Malarial Agents Targetting Apical Membrane Antigen

Norton, Raymond (Primary Chief Investigator (PCI))
McGowan, Sheena (Chief Investigator (CI))
Scammells, Peter (Chief Investigator (CI))
Scanlon, Martin (Chief Investigator (CI))

Project: Research

Status	Finished
Effective start/end date	1/01/12 → 31/12/14

Funding

National Health & Medical Research Council (NHMRC): AUD577,350.00

Related content

Research Output

Applications of ¹⁹F-NMR in fragment-based drug discovery

Research output: Contribution to journal › Review Article › Research › peer-review

Promiscuous 2-aminothiazoles (PrATs): a frequent hitting scaffold

Research output: Contribution to journal › Article › Research › peer-review

From crystal to compound: structure-based antimalarial drug discovery

Research output: Contribution to journal › Article › Research › peer-review

Operation of the Australian Store.Synchrotron for macromolecular crystallography

Research output: Contribution to journal › Article › Research › peer-review

Structure–activity studies of β-hairpin peptide inhibitors of the Plasmodium falciparum AMA1–RON2 interaction

Research output: Contribution to journal › Article › Research › peer-review

Understanding the structural dynamics of TCR-pMHC complex interactions

Research output: Contribution to journal › Article › Research › peer-review